Russell Investments Group, Ltd.
Position in RIGL — Rigel Pharmaceuticals Inc
CIK 1692234
Seattle, WA
Position in RIGL
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,973,196
+$943,306 QoQ
Shares Held
76,002
+1.2% QoQ
Ownership
0.407%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 156 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in RIGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. RIGL ranks #70 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
336,990 | $167,393,033 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
230,151 | $143,508,345 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,694,250 | $94,996,587 | |
| 4 | INCY |
Incyte Corp
|
425,616 | $48,247,822 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
158,228 | $47,631,369 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
783,148 | $44,811,725 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
120,304 | $38,026,888 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
418,025 | $34,098,295 |
All Filings in RIGL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,973,196 | 76,002 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $2,029,890 | 75,070 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $3,162,994 | 73,850 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,342,513 | 117,985 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $308,238 | 16,457 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $174,699 | 9,711 | Shares | Other | 2025-05-13 | |
| 2024-12-31 | $154,724 | 9,199 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $170,664 | 10,548 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $85,683 | 10,424 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $173,838 | 117,459 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $211,059 | 145,559 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $208,739 | 193,278 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $272,426 | 211,184 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $279,282 | 211,579 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $233,533 | 155,689 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $176,368 | 149,465 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $9,904 | 8,765 | Shares | Defined | 2022-07-29 | |
| 2022-03-31 | $272,749 | 91,221 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $210,867 | 79,573 | Shares | Defined | 2022-01-21 | |
| 2021-09-30 | $306,549 | 84,449 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $366,508 | 84,449 | Shares | Defined | 2021-08-04 | |
| 2021-03-31 | $880,655 | 257,502 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $2,099,810 | 599,946 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $2,233,314 | 930,548 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,150,246 | 628,550 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $721,907 | 462,762 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||